Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$0.96
$0.010.82%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 28.07% | -25.47% | 14.72% | -39.04% | -4.75% |
| Total Depreciation and Amortization | 8.41% | -0.65% | -21.31% | 28.92% | 34.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -80.37% | 100.15% | 541.41% | -120.21% | -49.98% |
| Change in Net Operating Assets | 33.45% | 73.75% | -216.38% | 27.70% | 190.34% |
| Cash from Operations | -9.49% | 453.32% | -111.55% | -17.33% | 223.69% |
| Capital Expenditure | -58.12% | 14.48% | 37.83% | -283.28% | -133.13% |
| Sale of Property, Plant, and Equipment | -95.76% | -- | -- | 340.42% | -46.23% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -124.14% | -158.25% | -72.56% | 122.70% | -618.59% |
| Cash from Investing | -75.15% | -53.90% | -125.06% | 94.91% | -548.70% |
| Total Debt Issued | -52.11% | 182.35% | 16.88% | -42.31% | -29.49% |
| Total Debt Repaid | 52.49% | -498.79% | 61.54% | 20.61% | 33.83% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | 96.63% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 100.00% | -4.87% | 11.85% | 14.33% |
| Other Financing Activities | 2.67% | 10.83% | 6.17% | -0.67% | -24.93% |
| Cash from Financing | -439.82% | 353.37% | 105.16% | -86.06% | 5.06% |
| Foreign Exchange rate Adjustments | 45.30% | -766.57% | -158.62% | -45.15% | 6.10% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -161.18% | 321.04% | -130.31% | -0.39% | 751.37% |